Check out this month’s issue highlights straight from the JDD Editor’s desk:
Assessing Implicit Bias in Dermatology analyses the results of a survey conducted with 220 dermatologists to determine the necessity for enhanced training and resources in order to support the increasingly diverse population.
Modified Fitzpatrick Scale-Skin Color and Reactivity presents a new system that can hel … Continue reading "JDD July 2023 Issue Highlights | Special Focus: Bridging The Gap in Dermatology"
SELF recently posted an article about the hidden mental health effects of eczema. How should dermatology clinicians approach their eczema patients about the mental impacts of this skin condition? When should a dermatologist refer to a mental health professional?
For expert advice, I reached out to dermatologist and clinical psychologist Richard Fried, MD, PhD, clinical director of Yardley Derm … Continue reading "Mental Health Effects of Eczema | The Expert Weighs In"
Tapinarof cream is a non-steroidal topical medication that was recently FDA approved in 2022 for the treatment of mild, moderate, or severe plaque psoriasis in adult patients. As biologic medications have continued to grow and become exceedingly present in the treatment of moderate to severe psoriasis, there has been very minimal, if any innovation in the space of topical treatments. Additionally, …